ARCH THERAPEUTICS INC News

ARCH THERAPEUTICS INC | 10-Q: Quarterly report

Futu NewsMay 9 15:48 · Announcements

Arch Therapeutics to Present AC5 Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)

FRAMINGHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), a marketer and developer of novel self-assembling wound care and biosurgical products, today announced

GlobeNewswireMay 6 05:50

Arch Therapeutics Provides Year End Operational Update

FRAMINGHAM, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), a marketer and developer of novel self-assembling wound care and biosurgical products, today provided

GlobeNewswireNov 9, 2023 05:50

Arch Therapeutics Files to List Stock, Warrants on Nasdaq

Arch Therapeutics Files to List Stock, Warrants on Nasdaq

Dow JonesNov 9, 2023 05:18

Arch Therapeutics Provides AC5 Commercialization Update

FRAMINGHAM, Mass., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), a marketer and developer of novel self-assembling wound care and biosurgical products, today

GlobeNewswireSep 13, 2023 05:45

Arch Therapeutics Completes Financing as Bridge to Uplisting

FRAMINGHAM, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), a marketer and developer of novel self-assembling wound care and biosurgical products, today

GlobeNewswireSep 7, 2023 18:14

Arch Therapeutics to Present AC5 Advanced Wound System at 2023 Symposium on Advanced Wound Care ("SAWC")

SAWC Spring 2023 represents first clinical conference opportunity to introduce newly effective dedicated AC5 HCPCS reimbursement codeFRAMINGHAM, Mass., April 25, 2023 (GLOBE NEWSWIRE) -- Arch Therap

GlobeNewswireApr 25, 2023 05:56

Dedicated HCPCS Billing Code for Arch Therapeutics' AC5 Advanced Wound System Now In Effect

FRAMINGHAM, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), a marketer and developer of novel self-assembling wound care and biosurgical products, today

GlobeNewswireApr 5, 2023 05:51

Arch Therapeutics' AC5® Advanced Wound System Receives Dedicated HCPCS Billing Code From The Centers for Medicare & Medicaid Services

FRAMINGHAM, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), a marketer and developer of novel self-assembling wound care and biosurgical products, today

GlobeNewswireMar 9, 2023 06:51

Arch Therapeutics Announces Addition of Contract Sales Force to Advance Commercialization of AC5® Advanced Wound System in Government Facilities

FRAMINGHAM, Mass., March 07, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), a marketer and developer of novel self-assembling wound care and biosurgical products, today

GlobeNewswireMar 7, 2023 06:51

Arch Therapeutics Announces Formation of Medical Advisory Board to Advance Commercialization of AC5® Advanced Wound System

FRAMINGHAM, Mass., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), a marketer and developer of novel self-assembling wound care and biosurgical products, today

GlobeNewswireJan 18, 2023 06:36

Arch Announces 1-for-200 Reverse Stock Split

Seeking AlphaJan 17, 2023 15:31

Arch Announces One-for-Two-Hundred Reverse Stock Split in Connection With Application for Uplisting to a National Exchange

FRAMINGHAM, Mass., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), a marketer and developer of novel self-assembling wound care and biosurgical

GlobeNewswireJan 17, 2023 15:06

The Centers for Medicare & Medicaid Services Makes Preliminary Recommendation to Establish New HCPCS Billing Code Dedicated to Arch Therapeutics' AC5® Advanced Wound System

FRAMINGHAM, Mass., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), a marketer and developer of novel self-assembling wound care and biosurgical products, today

GlobeNewswireDec 5, 2022 05:51

Arch Therapeutics’ AC5® Advanced Wound System to Be Presented With Honors at 2022 Symposium on Advanced Wound Care (SAWC) Fall

Awarded Highest Scoring Poster Abstract in Case Series / Study CategoryFRAMINGHAM, Mass., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a markete

GlobeNewswireOct 11, 2022 05:50

Arch Therapeutics Announces First Shipments of AC5® Advanced Wound System Under New Reimbursement Support Program

Significant Milestone in Commercialization Plan Expected to Drive Sales MomentumFRAMINGHAM, Mass., Sept. 23, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"),

GlobeNewswireSep 23, 2022 05:55

Arch Therapeutics Accepted to Present AC5® Advanced Wound System During Innovation Spotlight at 2022 Symposium on Advanced Wound Care (SAWC)

Prestigious Honor Supports Increasing Interest in Broad Clinical Benefits of Synthetic Products in Wound HealingFRAMINGHAM, Mass., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:

GlobeNewswireSep 20, 2022 05:55

Arch Therapeutics Announces Intent to Uplist From OTC to a National Exchange

Consistent with Long-Term Strategic Plan to Increase Capital Market Visibility and Enhance Access to Growth CapitalFRAMINGHAM, Mass., Sept. 16, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQ

GlobeNewswireSep 16, 2022 05:55

Arch Therapeutics Launches Multi-Site Clinical Study for AC5® Advanced Wound System

Expected to Accelerate Sales Opportunities in Doctor's Office and Wound ClinicsFRAMINGHAM, Mass., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"),

GlobeNewswireSep 7, 2022 05:55

Arch Therapeutics Submits Application to Centers for Medicare and Medicaid Services for AC5® Advanced Wound System

HCPCS Code May Support Product Differentiation and Enhance Existing Sales Opportunities Under New CMS 2022 Billing and Reimbursement Pathway for Synthetic Skin SubstitutesFRAMINGHAM, Mass., Sept. 01,

GlobeNewswireSep 1, 2022 05:55